Healthcare provider profile · identity verified

Andre' Van Mol, MD

Family Practice · REDDING, CA · NPI 1083603203

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	483	146
Levothyroxine Sodium	Levothyroxine Sodium	418	106
Gabapentin	Gabapentin	198	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	193	41
Losartan Potassium	Losartan Potassium	187	52
Lisinopril	Lisinopril	186	55
Amlodipine Besylate	Amlodipine Besylate	174	52
Pantoprazole Sodium	Pantoprazole Sodium	174	59
Omeprazole	Omeprazole	152	48
Tamsulosin Hcl	Tamsulosin Hcl	142	45
Zolpidem Tartrate	Zolpidem Tartrate	136	30
Rosuvastatin Calcium	Rosuvastatin Calcium	134	36
Pravastatin Sodium	Pravastatin Sodium	119	31
Escitalopram Oxalate	Escitalopram Oxalate	109	26
Metformin Hcl	Metformin Hcl	103	28
Albuterol Sulfate Hfa	Albuterol Sulfate	100	36
Montelukast Sodium	Montelukast Sodium	98	24
Meloxicam	Meloxicam	96	29
Olmesartan Medoxomil	Olmesartan Medoxomil	90	25
Alprazolam	Alprazolam	89	19
Metformin Hcl Er	Metformin Hcl	89	25
Ezetimibe	Ezetimibe	88	25
Glimepiride	Glimepiride	88	26
Celecoxib	Celecoxib	82	22
Tramadol Hcl	Tramadol Hcl	80	26
Duloxetine Hcl	Duloxetine Hcl	79	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	77	62
Pioglitazone Hcl	Pioglitazone Hcl	75	22
Allopurinol	Allopurinol	74	20
Metoprolol Tartrate	Metoprolol Tartrate	73	22
Synthroid	Levothyroxine Sodium	70	21
Bupropion Xl	Bupropion Hcl	67	16
Metoprolol Succinate	Metoprolol Succinate	67	18
Simvastatin	Simvastatin	64	22
Fluticasone Propionate	Fluticasone Propionate	61	21
Baclofen	Baclofen	56	13
Eliquis	Apixaban	56	11
Carvedilol	Carvedilol	54	15
Azithromycin	Azithromycin	52	47
Irbesartan	Irbesartan	52	16
Hydrochlorothiazide	Hydrochlorothiazide	49	13
Jardiance	Empagliflozin	45	12
Fluoxetine Hcl	Fluoxetine Hcl	44	11
Propranolol Hcl	Propranolol Hcl	42	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	42	11
Clopidogrel	Clopidogrel Bisulfate	40	13
Testosterone	Testosterone	40	suppressed
Clonazepam	Clonazepam	39	suppressed
Ozempic	Semaglutide	39	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	38	suppressed
Pregabalin	Pregabalin	38	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	38	28
Valsartan	Valsartan	37	11
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Finasteride	Finasteride	36	11
Furosemide	Furosemide	36	15
Potassium Chloride	Potassium Chloride	35	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	26
Tradjenta	Linagliptin	32	suppressed
Lorazepam	Lorazepam	31	11
Januvia	Sitagliptin Phosphate	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Morphine Sulfate Er	Morphine Sulfate	29	suppressed
Sertraline Hcl	Sertraline Hcl	28	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	28	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	27	suppressed
Famotidine	Famotidine	27	11
Atenolol	Atenolol	26	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Doxepin Hcl	Doxepin Hcl	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	11
Tizanidine Hcl	Tizanidine Hcl	24	18
Lansoprazole	Lansoprazole	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Prednisone	Prednisone	22	17
Alendronate Sodium	Alendronate Sodium	21	suppressed
Cephalexin	Cephalexin	21	suppressed
Breyna	Budesonide/Formoterol Fumarate	20	suppressed
Dutasteride	Dutasteride	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Trazodone Hcl	Trazodone Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	15
Farxiga	Dapagliflozin Propanediol	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	13
Estradiol	Estradiol	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Temazepam	Temazepam	14	suppressed
Topiramate	Topiramate	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Wellbutrin Sr	Bupropion Hcl	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error